Patents by Inventor Erik A. Berglund

Erik A. Berglund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240101671
    Abstract: Provided herein are methods for inducing tolerance to an organ (e.g., liver) transplant in a patient. Compositions for use with these methods and kits are also disclosed.
    Type: Application
    Filed: January 20, 2022
    Publication date: March 28, 2024
    Inventor: Erik BERGLUND
  • Patent number: 11834522
    Abstract: A methyl ethyl hydroxyalkyl cellulose (MEHEC), process for making the MEHEC, and a powder containing the MEHEC are disclosed. The MEHEC is provided with a DSmethyl from 1.5 to 2.5, a DSethyl from 0.005 to 0.15, and a MSalkylene-oxide from 0.005 to 0.2. The methyl ethyl hydroxyalkyl cellulose optionally includes an anti-oxidant. The MEHEC optionally does not have a combination of a DSmethyl of 2.2 or 1.8, a DSethyl of 0.05 or 0.1, and a MSalkylene-oxide of 0.1 and does not have a combination of a DSmethyl of 2.5 or 2.0, a DSethyl of 0.1, and a MSalkylene-oxide of 0.05. The MEHEC has very good biostability and is suitable for use in the building industry.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: December 5, 2023
    Assignee: NOURYON CHEMICALS INTERNATIONAL B.V.
    Inventors: Leif Magnus Joakim Anger, Kjell Stridh, Lars Erik Berglund, Alexander Zapf
  • Publication number: 20230365687
    Abstract: Provided herein are improved anti-CD2 antibodies and methods for their use in the treatment and/or prevention of chronic or acute disorders of the immune system. Also provided herein are methods for treating or preventing an immune related disorder or disease in a subject by administering an anti-CD2 antibody or an antigen-binding fragment thereof and a CTLA-4 co-stimulation blockade. Compositions for use with these methods and kits are also disclosed.
    Type: Application
    Filed: June 22, 2021
    Publication date: November 16, 2023
    Inventors: David Berglund, Erik Berglund, Felix Sellberg, Christian Binder
  • Publication number: 20230323468
    Abstract: This invention relates to methods for selecting a treatment and optionally treating subjects with muscle-invasive bladder cancer based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: August 27, 2021
    Publication date: October 12, 2023
    Inventors: Roger Li, James J. Mulé, Anders Erik Berglund
  • Publication number: 20220401470
    Abstract: The present invention provides a polymer comprising a carbazate-modified polyvinyl alcohol (PVAC) according to Formula I for use in preventing, alleviating, and/or treating cancer, and a method for producing said compound.
    Type: Application
    Filed: November 18, 2020
    Publication date: December 22, 2022
    Inventors: David BERGLUND, Erik BERGLUND, Felix SELLBERG, Robin FRÖBOM
  • Publication number: 20200262934
    Abstract: A methyl ethyl hydroxyalkyl cellulose (MEHEC), process for making the MEHEC, and a powder containing the MEHEC are disclosed. The MEHEC is provided with a DSmethyl from 1.5 to 2.5, a DSethyl from 0.005 to 0.15, and a MSalkylene-oxide from 0.005 to 0.2. The methyl ethyl hydroxyalkyl cellulose optionally includes an anti-oxidant. The MEHEC optionally does not have a combination of a DSmethyl of 2.2 or 1.8, a DSethyl of 0.05 or 0.1, and a MSalkylene-oxide of 0.1 and does not have a combination of a DSmethyl of 2.5 or 2.0, a DSethyl of 0.1, and a MSalkylene-oxide of 0.05. The MEHEC has very good biostability and is suitable for use in the building industry.
    Type: Application
    Filed: August 14, 2018
    Publication date: August 20, 2020
    Applicant: NOURYON CHEMICALS INTERNATIONAL B.V.
    Inventors: Leif Magnus Joakim ANGER, Kjell STRIDH, Lars Erik BERGLUND, Alexander ZAPF
  • Patent number: 10583183
    Abstract: This invention relates to methods for treating subjects with bladder cancer, such as urothelial carcinoma, based on mRNA expression levels of chemokines.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: March 10, 2020
    Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Anthony M. Magliocco, James J. Mulé, Anders Erik Berglund
  • Patent number: 9751918
    Abstract: The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: September 5, 2017
    Assignee: XERAGENX LLC
    Inventors: Lars Erik Berglund, Torben Ellebaek Petersen, Sergey Nikolaevich Fedosov, Ebba Nexo, Niels Bech Laursen, Erik Ostergaard Jensen
  • Patent number: 9737087
    Abstract: A composition that is a substitute for food grade sodium chloride includes crystalline particles containing both potassium chloride and lysine monohydrochloride such that the potassium chloride and lysine monohydrochloride are not susceptible to separation. A process for making the composition includes steps of providing a supersaturated water solution of potassium chloride and lysine monohydrochloride at a temperature of from about 10 to about 70° C., adding ethanol to the solution in an amount sufficient to precipitate crystalline particles containing a combination of potassium chloride and lysine monohydrochloride, separating the crystalline particles from the solution, and drying the crystalline particles.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: August 22, 2017
    Assignee: Working Bugs, LLC
    Inventors: Kris A. Berglund, Erik A. Berglund
  • Publication number: 20170175199
    Abstract: This invention relates to methods for selecting a treatment, treating, and predicting survival time in subjects with cancer, such as colorectal cancer, based on tumor expression levels of chemokines, cytotoxic genes, and/or dendritic cell genes.
    Type: Application
    Filed: April 10, 2015
    Publication date: June 22, 2017
    Inventors: Anthony M. MAGLIOCCO, James J. MULE, Anders Erik BERGLUND
  • Patent number: 9523014
    Abstract: The invention relates to a process for grinding cellulose ether comprising the steps of: a) grinding a cellulose ether comprising 20 to 90 wt % of water, based on the total weight of cellulose ether and water, and a cationic surfactant in a mill; and b) optionally drying the mixture while grinding, prior to or following the step of grinding.
    Type: Grant
    Filed: May 9, 2006
    Date of Patent: December 20, 2016
    Assignee: AKZO NOBEL N.V.
    Inventors: Lars Erik Berglund, Birgit Tora Gunvor Karlsson
  • Publication number: 20160037813
    Abstract: A composition that is a substitute for food grade sodium chloride includes crystalline particles containing both potassium chloride and lysine monohydrochloride such that the potassium chloride and lysine monohydrochloride are not susceptible to separation. A process for making the composition includes steps of providing a supersaturated water solution of potassium chloride and lysine monohydrochloride at a temperature of from about 10 to about 70° C., adding ethanol to the solution in an amount sufficient to precipitate crystalline particles containing a combination of potassium chloride and lysine monohydrochloride, separating the crystalline particles from the solution, and drying the crystalline particles.
    Type: Application
    Filed: October 22, 2015
    Publication date: February 11, 2016
    Applicant: Working Bugs, LLC
    Inventors: Kris A. Berglund, Erik A. Berglund
  • Patent number: 9204663
    Abstract: A composition that is a substitute for food grade sodium chloride includes crystalline particles containing both potassium chloride and lysine monohydrochloride such that the potassium chloride and lysine monohydrochloride are not susceptible to separation. A process for making the composition includes steps of providing a supersaturated water solution of potassium chloride and lysine monohydrochloride at a temperature of from about 10 to about 70° C., adding ethanol to the solution in an amount sufficient to precipitate crystalline particles containing a combination of potassium chloride and lysine monohydrochloride, separating the crystalline particles from the solution, and drying the crystalline particles.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: December 8, 2015
    Assignee: Working Bugs, LLC
    Inventors: Kris A. Berglund, Erik A. Berglund, Dianne Holman
  • Publication number: 20150157731
    Abstract: The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
    Type: Application
    Filed: February 19, 2015
    Publication date: June 11, 2015
    Inventors: Lars Erik Berglund, Torben Eilebaek Petersen, Sergey Nikolaevich Fedosov, Ebba Nexo, Niels Bech Laursen, Erik Ostergaard Jensen
  • Publication number: 20150158920
    Abstract: The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
    Type: Application
    Filed: February 19, 2015
    Publication date: June 11, 2015
    Inventors: Lars Erik Berglund, Torben Eilebaek Petersen, Sergey Nikolaevich Fedosov, Ebba Nexo, Niels Bech Laursen, Erik Ostergaard Jensen
  • Publication number: 20150158922
    Abstract: The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
    Type: Application
    Filed: February 19, 2015
    Publication date: June 11, 2015
    Inventors: Lars Erik Berglund, Torben Eilebaek Petersen, Sergey Nikolaevich Fedosov, Ebba Nexo, Niels Bech Laursen, Erik Ostergaard Jensen
  • Publication number: 20100184642
    Abstract: The present invention relates to the use of transgenic plants for the expression of vitamin B12 (cobalamin) binding proteins. Plant cells are transformed with nucleotide sequences adapted for expression and secretion of vitamin B12 binding proteins. The present invention also relates to the use of recombinant vitamin B12 binding proteins from plants in analytical tests and treatment of vitamin B12 deficiency. Also disclosed is a method for purification of recombinant vitamin B12 binding proteins.
    Type: Application
    Filed: January 22, 2009
    Publication date: July 22, 2010
    Applicant: DrugTech Corporation
    Inventors: Lars Erik Berglund, Torben Ellebaek Petersen, Sergey Nikolaevich Fedosov, Ebba Nexo, Niels Bech Laursen, Erik Ostergaard Jensen
  • Publication number: 20090285165
    Abstract: A method includes receiving at a gateway mesh node a channel set list indicating radio channels that are allowed for use by the gateway mesh node, scanning channels in the channel set list and creating a list of channels in order of interference that is present, allocating channels from the list of channels to a plurality of radios that comprise the gateway mesh node, and initiating transmission of beacon frames from each of the plurality of radios on a main channel. Each beacon frame includes information descriptive of a path cost representing a sum of all link costs back to a central point, a primary radio channel used by the radio transmitting the beacon frame, a channel set indicating only those channels that an associated portion of the mesh network is allowed to use, and a set of meshed nodes associated with the radio.
    Type: Application
    Filed: May 16, 2008
    Publication date: November 19, 2009
    Inventors: Jan Erik Berglund, Zheng Li, Kevin Tang
  • Publication number: 20080255956
    Abstract: A system and a method for creating a personal website in a public website on the Internet. At least one RFID transponder is intended to be placed at a physical sales meeting premise. A website configuration system includes an element to create the personal website in the public website on the Internet. At least one portable unit includes an RFID reader and an element for wirelessly communicating data to the website configuration system. Each portable unit is arranged to send data, which via its RFID reader has been read from at least one RFID transponder, to the website configuration system, which is arranged to create the personal website in the public website on the Internet based on said data.
    Type: Application
    Filed: January 17, 2006
    Publication date: October 16, 2008
    Applicant: OMNITUS AB
    Inventors: Erik Berglund, Magnus Bang, Anders Larsson
  • Publication number: 20080216023
    Abstract: A method and a system for creating a website guide assisting in finding information on a website. A guide editor includes information on how to generate a graphical user interface allowing a user to specify a page on the website, and instructions on how to generate a view showing a graphical input object superimposed on the specified page on the website allowing a first person to enter links to selected information on the website. A first computer device includes a first graphical generator adapted to generate and display the graphical user interface and the view. Data storage stores guide data including an address to the specified page on the website, links to the selected information, and instructions on how to create a website guide in response to a request from a second person. The website shows a graphical message object superimposed on the specified page of the website. The graphical message object includes link elements which, upon activation, display the selected information on the website.
    Type: Application
    Filed: March 2, 2007
    Publication date: September 4, 2008
    Applicant: Omnitus AB
    Inventors: Erik Berglund, Magnus Bang, Anders Larsson